Rapport Therapeutics, Inc. - Common Stock, $0.001 par value per share (RAPP)

CUSIP: 75383L102

Q2 2025 13F Holders as of 30 Jun 2025

Holder snapshot 6 signals
Share change
+391,478
SEC-reported price per share
$11.37
Number of holders
81
Value change
+$4,896,059
Number of buys
41
Number of sells
28
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
47,942,939

Security key

75383L102

Report period

Q2 2025

Institutions

81

Top holders

10

Ownership snapshot

Top reported holders of RAPP - Rapport Therapeutics, Inc. - Common Stock, $0.001 par value per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
ARCH Venture Partners XII...
Disclosed value leader
TRV GP V, LLC
Comparable rows
0/15
Latest evidence
31 Mar 2025
3/4/5 13F Highest disclosed value: $71,566,387 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

TRV GP V, LLC has the largest disclosed position value at $71.57M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens TRV GP V, LLC's linked filing trail.
Disclosed position value Top 5
ARCH Venture Partners XII, LLC $37.21M
TRV GP V, LLC $71.57M
FMR LLC $55.03M
ARCH Venture Management, LLC $37.55M
Cormorant Asset Management, LP $29.5M

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
ARCH Venture Partners XII, LLC
3/4/5
10%+ Owner
—
denominator unverified
$37,212,805
3,728,738 shares
— 10 Jun 2024
TRV GP V, LLC
13F
Company
13F
—
denominator unverified
$71,566,387
7,135,233 shares
— 31 Mar 2025
FMR LLC
13F
Company
13F
—
denominator unverified
$55,029,274
5,486,468 shares
— 31 Mar 2025
ARCH Venture Management, LLC
13F
Company
13F
—
denominator unverified
$37,548,392
3,728,738 shares
— 31 Mar 2025
Cormorant Asset Management, LP
13F
Company
13F
—
denominator unverified
$29,497,438
2,940,921 shares
— 31 Mar 2025
Capital International Investors
13F
Company
13F
—
denominator unverified
$26,103,366
2,602,529 shares
— 31 Mar 2025
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q2 2025

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
81
Shares
38,494,803
Rows available
81
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q2 2025 vs Q1 2025 Across Filers

Q1 2025 holders
77
Q2 2025 holders
81
Holder diff
4
Investor Q1 2025 Shares Q2 2025 Shares Share Diff Share Chg % Q1 2025 value Q2 2025 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .